NCT00365248View on ClinicalTrials.gov

TachoSil Paediatric Liver Trial (TC-019-IN)

PHASE3CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

October 31, 2005

Study Completion Date

May 31, 2008

Conditions

Liver Diseases

Interventions

DRUG

Fibrinogen human (TachoSil)

Resection of the liver with or without segmental liver transplantation

Trial Locations (1)

4000

Nycomed, Roskilde

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Nycomed

INDUSTRY